Sabra Healthcare REIT (NASDAQ:SBRA) Hits New 12-Month High – What’s Next?

Posted by Francis Steltz on Jul 28th, 2026

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Get Free Report) reached a new 52-week high during trading on Tuesday . The company traded as high as $22.77 and last traded at $22.6080, with a volume of 68423 shares. The stock had previously closed at $22.39.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the stock. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Sabra Healthcare REIT in a research note on Wednesday, July 22nd. Citizens Jmp lifted their target price on shares of Sabra Healthcare REIT from $23.00 to $25.00 and gave the stock a “market outperform” rating in a report on Wednesday, July 22nd. Robert W. Baird upped their target price on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 22nd. Barclays started coverage on shares of Sabra Healthcare REIT in a report on Tuesday, July 7th. They set an “overweight” rating and a $21.00 price target on the stock. Finally, Scotiabank reduced their price target on shares of Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating for the company in a research report on Thursday, June 18th. Eight analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $22.25.

Read Our Latest Analysis on SBRA

Sabra Healthcare REIT Price Performance

The stock has a market capitalization of $5.68 billion, a P/E ratio of 35.71, a price-to-earnings-growth ratio of 1.73 and a beta of 0.65. The business’s 50 day moving average price is $19.71 and its 200 day moving average price is $19.86. The company has a debt-to-equity ratio of 0.96, a current ratio of 4.72 and a quick ratio of 4.72.

Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last issued its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.16. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The company had revenue of $211.74 million for the quarter, compared to analysts’ expectations of $209.20 million. During the same quarter last year, the company posted $0.37 earnings per share. The firm’s quarterly revenue was up 20.9% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Sell-side analysts forecast that Sabra Healthcare REIT, Inc. will post 1.51 EPS for the current year.

Sabra Healthcare REIT Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, May 29th. Stockholders of record on Friday, May 15th were paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 5.3%. The ex-dividend date was Friday, May 15th. Sabra Healthcare REIT’s dividend payout ratio is 190.48%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Sumitomo Mitsui Trust Group Inc. boosted its holdings in Sabra Healthcare REIT by 6.8% in the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,208,600 shares of the real estate investment trust’s stock worth $61,701,000 after buying an additional 203,226 shares during the period. Principal Financial Group Inc. raised its stake in Sabra Healthcare REIT by 21.6% during the fourth quarter. Principal Financial Group Inc. now owns 24,953,351 shares of the real estate investment trust’s stock valued at $472,617,000 after purchasing an additional 4,431,897 shares in the last quarter. Legal & General Group Plc increased its holdings in shares of Sabra Healthcare REIT by 16.5% in the 4th quarter. Legal & General Group Plc now owns 1,427,180 shares of the real estate investment trust’s stock worth $27,031,000 after buying an additional 201,667 shares during the last quarter. UBS Group AG boosted its position in shares of Sabra Healthcare REIT by 143.1% during the fourth quarter. UBS Group AG now owns 1,460,219 shares of the real estate investment trust’s stock valued at $27,657,000 after buying an additional 859,584 shares during the period. Finally, Lasalle Investment Management Securities LLC bought a new stake in Sabra Healthcare REIT during the 4th quarter valued at $66,938,000. Hedge funds and other institutional investors own 99.40% of the company’s stock.

About Sabra Healthcare REIT

(Get Free Report)

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.